These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11502013)

  • 1. The financial impact of smoking on health-related costs: a review of the literature.
    Max W
    Am J Health Promot; 2001; 15(5):321-31. PubMed ID: 11502013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial impact of health promotion programs: a comprehensive review of the literature.
    Aldana SG
    Am J Health Promot; 2001; 15(5):296-320. PubMed ID: 11502012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between smoking and health care, workers' compensation, and productivity costs for a large employer.
    Sherman BW; Lynch WD
    J Occup Environ Med; 2013 Aug; 55(8):879-84. PubMed ID: 23924829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
    O'Donnell MP; Roizen MF
    Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review and analysis of the clinical- and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update.
    Pelletier KR
    Am J Health Promot; 2001; 16(2):107-16. PubMed ID: 11727590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco Cost of Illness Studies: A Systematic Review.
    Makate M; Whetton S; Tait RJ; Dey T; Scollo M; Banks E; Norman R; Pidd K; Roche AM; Allsop S
    Nicotine Tob Res; 2020 Apr; 22(4):458-465. PubMed ID: 30874290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical costs of smoking in the United States: estimates, their validity, and their implications.
    Warner KE; Hodgson TA; Carroll CE
    Tob Control; 1999; 8(3):290-300. PubMed ID: 10599574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workplace smoking related absenteeism and productivity costs in Taiwan.
    Tsai SP; Wen CP; Hu SC; Cheng TY; Huang SJ
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i33-7. PubMed ID: 15923446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.
    Asay GR; Roy K; Lang JE; Payne RL; Howard DH
    Prev Chronic Dis; 2016 Oct; 13():E141. PubMed ID: 27710764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between return on investment and quality of study methodology in workplace health promotion programs.
    Baxter S; Sanderson K; Venn AJ; Blizzard CL; Palmer AJ
    Am J Health Promot; 2014; 28(6):347-63. PubMed ID: 24977496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of workplace wellness programmes in Canada.
    Jacobs JC; Yaquian E; Burke SM; Rouse M; Zaric G
    Occup Med (Lond); 2017 Aug; 67(6):429-434. PubMed ID: 28898961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shining lights: studies that have most influenced the understanding of health promotion's financial impact.
    Golaszewski T
    Am J Health Promot; 2001; 15(5):332-40. PubMed ID: 11502014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of smoking among active duty U.S. Air Force personnel--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 May; 49(20):441-5. PubMed ID: 10843504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of depression in 1990.
    Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
    J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total costs of IBS: employer and managed care perspective.
    Cash B; Sullivan S; Barghout V
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.